Welcome to our book review site go-pdf.online!

You may have to Search all our reviewed books and magazines, click the sign up button below to create a free account.

Sign up

Cancer Chemotherapy, Immunotherapy, and Biotherapy
  • Language: en

Cancer Chemotherapy, Immunotherapy, and Biotherapy

  • Type: Book
  • -
  • Published: 2018
  • -
  • Publisher: LWW

Publisher's Note: Products purchased from 3rd Party sellers are not guaranteed by the Publisher for quality, authenticity, or access to any online entitlements included with the product. Thoroughly revised and reformatted, the sixth edition of Cancer Chemotherapy, Immunotherapy and Biotherapy reflects recent significant changes in cancer treatment. This newly streamlined edition contains full-color illustrations, more tables for quick reference, and new immunotherapy and molecular targeted therapy content that brings you fully up to date with the state of the art in all current cancer therapies. Provides thorough, comprehensive coverage of the scientific and clinical aspects of immunotherapy...

Cancer Chemotherapy and Biotherapy
  • Language: en
  • Pages: 836

Cancer Chemotherapy and Biotherapy

Updated to include the newest drugs and those currently in development, this Fifth Edition is a comprehensive reference on the preclinical and clinical pharmacology of anticancer agents. Organized by drug class, the book provides the latest information on all drugs and biological agents—their mechanisms of action, interactions with other agents, toxicities, side effects, and mechanisms of resistance. The authors explain the rationale for use of drugs in specific schedules and combinations and offer guidelines for dose adjustment in particular situations. This edition's introduction includes timely information on general strategies for drug usage, the science of drug discovery and development, economic and regulatory aspects of cancer drug development, and principles of pharmacokinetics. Eight new chapters have been added and more than twenty have been significantly revised. A companion website includes the fully searchable text and an image bank.

Harrison's Manual of Oncology
  • Language: en
  • Pages: 648

Harrison's Manual of Oncology

Lange Q&A: Mammography Examination is a comprehensive study guide for the ARRT’s Mammography Examination. The book summarizes the mammography curriculum in a clear and concise format and includes review Q&A plus two complete practice exams. With this book, radiographic technicians get the practice they need to pass the registry examination with flying colors.

Harrisons Manual of Oncology 2/E
  • Language: en
  • Pages: 897

Harrisons Manual of Oncology 2/E

A CONCISE YET THOROUGH OVERVIEW OF THE MEDICATIONS AND APPROACHES USED IN CANCER CARE--BACKED BY THE AUTHORITY OF HARRISON'S Harrison's Manual of Oncology is a carry-anywhere guide to the care of patients with cancer. Enhanced by the latest published results, this valuable clinical companion features numerous tables and succinct, outline-style text that puts important information at your fingertips. You will find content that goes beyond the treatment of primary or metastatic disease to encompass the treatment of all therapeutic complications. The opening sections of Harrison's Manual of Oncology are devoted to the classes of agents used to treat cancer and reviews their pharmacology and mechanisms of action. This section is followed by a detailed discussion of the diagnosis, staging, and treatment of all major types of cancer. There is a strong focus on symptom management and complications of treatment, including pain, nausea and vomiting, anemia, febrile neutropenia, metabolic emergencies, thrombosis, psychological issues, and end-of-life care.

Goodman and Gilman's The Pharmacological Basis of Therapeutics
  • Language: en
  • Pages: 1916

Goodman and Gilman's The Pharmacological Basis of Therapeutics

**** A classic text, now in its 50th year, recommended as a first purchase by Brandon-Hill. The new edition reflects the impact of modern biology since the previous edition in 1985: novel drugs produced by recombinant DNA technology, detailed knowledge of the structure and function of dozens of receptors, major progress in rational drug design, and improved treatment from appreciation of the importance of interplay between pharmacodynamics and pharmacokinetics. Annotation copyrighted by Book News, Inc., Portland, OR

Treatment of Cancer
  • Language: en
  • Pages: 880

Treatment of Cancer

  • Type: Book
  • -
  • Published: 2014-10-29
  • -
  • Publisher: CRC Press

Treatment of Cancer, Sixth Edition is a multi-authored work based on a single theme-the optimal treatment of cancer. A comprehensive guide to modern cancer treatment, it supports an integrated approach to patient care including radiotherapy, chemotherapy and surgery. The sixth edition has been completely updated to create a useful, practical guide

Extracranial Stereotactic Radiotherapy and Radiosurgery
  • Language: en
  • Pages: 368

Extracranial Stereotactic Radiotherapy and Radiosurgery

  • Type: Book
  • -
  • Published: 2005-11-01
  • -
  • Publisher: CRC Press

For radiation oncologists and physicists who want an authoritative overview of emerging developments in the field, as well as clear direction on the utilization of this new technology in clinical practice, this reference provides in-depth descriptions of new and promising stereotactic methods for the application of stereotactic radiotherapy for the treatment of extracranial tumors.

The NIH Record
  • Language: en
  • Pages: 338

The NIH Record

  • Type: Book
  • -
  • Published: 1990
  • -
  • Publisher: Unknown

None

A Time to Dive
  • Language: en

A Time to Dive

  • Type: Book
  • -
  • Published: 2020-08-02
  • -
  • Publisher: Unknown

An above and underwater autobiographical journey of a commercial diver, chronicling experiences from the Gulf coast to the Alaskan outer islands.

How We Do Harm
  • Language: en
  • Pages: 320

How We Do Harm

How We Do Harm exposes the underbelly of healthcare today—the overtreatment of the rich, the under treatment of the poor, the financial conflicts of interest that determine the care that physicians' provide, insurance companies that don't demand the best (or even the least expensive) care, and pharmaceutical companies concerned with selling drugs, regardless of whether they improve health or do harm. Dr. Otis Brawley is the chief medical and scientific officer of The American Cancer Society, an oncologist with a dazzling clinical, research, and policy career. How We Do Harm pulls back the curtain on how medicine is really practiced in America. Brawley tells of doctors who select treatment ...